Patents by Inventor Thomas Meredydd Morris

Thomas Meredydd Morris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080161404
    Abstract: The present invention relates to a method of treating a metastatic prostate cancer patient by administering to said patient an effective amount of a bicalutamide (4?-cyano-??,??,??-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono-m-toluidide) containing formulation capable of delivering at least a mean steady state plasma level of (R)-bicalutamide enantiomer of 40 ?g/ml; and to bicalutamide containing products and formulations capable of delivering the at least mean steady state plasma level of (R)-bicalutamide enantiomer of 40 ?g/ml to a patient in need thereof.
    Type: Application
    Filed: February 21, 2006
    Publication date: July 3, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Kevin Joseph Carroll, Thomas Meredydd Morris, Ian Derek Cockshott, Bo-Eric Persson, Paul Alfred Dickinson